These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Fixation and central visual field after perifoveal krypton laser treatment of subfoveal neovascularizations. Schneider U; Kuck H; Kreissig I Eur J Ophthalmol; 1993; 3(4):193-200. PubMed ID: 7511450 [TBL] [Abstract][Full Text] [Related]
30. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol; 1993 Sep; 111(9):1189-99. PubMed ID: 7689826 [TBL] [Abstract][Full Text] [Related]
31. One-year results from clinical practice of epimacular strontium-90 brachytherapy for the treatment of subfoveal choroidal neovascularization secondary to AMD. Zur D; Loewenstein A; Barak A Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):338-43. PubMed ID: 25856820 [TBL] [Abstract][Full Text] [Related]
32. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Lewis H; Kaiser PK; Lewis S; Estafanous M Am J Ophthalmol; 1999 Aug; 128(2):135-46. PubMed ID: 10458168 [TBL] [Abstract][Full Text] [Related]
33. Scatter macular photocoagulation for subfoveal neovascular membranes in age-related macular degeneration. A pilot study. Tornambe PE; Poliner LS; Hovey LJ; Taren D Retina; 1992; 12(4):305-14. PubMed ID: 1283021 [TBL] [Abstract][Full Text] [Related]
34. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol; 1991 Sep; 109(9):1220-31. PubMed ID: 1718250 [TBL] [Abstract][Full Text] [Related]
35. Interferon alpha-2a in the treatment of exudative senile macular degeneration. Jaakkola A; Anttila PM; Immonen I Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027 [TBL] [Abstract][Full Text] [Related]
36. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Bressler NM; Maguire MG; Murphy PL; Alexander J; Margherio R; Schachat AP; Fine SL; Stevens TS; Bressler SB Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976 [TBL] [Abstract][Full Text] [Related]
37. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. Verteporfin In Photodynamic Therapy Study Group Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929 [TBL] [Abstract][Full Text] [Related]
38. Visual results after submacular surgery for neovascularization in age-related macular degeneration. Roth DB; Downie AA; Charles ST Ophthalmic Surg Lasers; 1997 Nov; 28(11):920-5. PubMed ID: 9387179 [TBL] [Abstract][Full Text] [Related]
39. Treatment of foveal pigment epithelial detachments with contiguous extrafoveal choroidal neovascular membranes. Maguire JI; Benson WE; Brown GC Am J Ophthalmol; 1990 May; 109(5):523-9. PubMed ID: 1692183 [TBL] [Abstract][Full Text] [Related]